ArticleJournal of pharmacy & bioallied sciences2026
Study of Respiratory and Hemodynamic Variables in Patients Receiving either Volume Control Ventilation or Pressure Control Ventilation during Laparoscopic Surgeries.
Article in Journal of pharmacy & bioallied sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate respiratory and hemodynamic variables in patients receiving volume-controlled ventilation (VCV) versus pressure-controlled ventilation (PCV) during laparoscopic surgeries. Methods: Sixty ASA grade I-II patients, aged 18-60 years, with a body mass index (BMI) under 30, scheduled for elective laparoscopic procedures, were enrolled. Group A was sustained on VCV, but Group B transitioned to PCV after 15 min of VCV. Ventilation parameters were established with a tidal volume of 6 mL/kg, a respiratory rate of 12 breaths per minute, and a PEEP of 5 cm H₂O. Hemodynamic and respiratory parameters (systolic and diastolic blood pressure (SBP, DBP), MAP, heart rate (HR), oxygen saturation (SpO₂), capnography (EtCO₂), and peak airway pressure (Ppeak)) were documented at intervals of 15 min. Results: Group A exhibited markedly elevated heart rate and mean arterial pressure (MAP) at multiple intervals ( Conclusion: PCV demonstrated reduced lower airway pressures and enhanced hemodynamic stability relative to VCV in non-obese ASA I-II individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.